Bespoke Extracts Reports Preliminary Revenue Growth Amid Filing Delay

Bespoke Extracts projects $1.5M in FY 2025 revenue, a 34% increase, as it secures an SEC extension to file its full annual report in mid-April.

Cannabis company Bespoke Extracts has provided a preliminary look at its financial performance for fiscal year 2025, revealing significant revenue growth. This update comes as the company secures an extension for filing its complete annual report with regulators.

Preliminary Figures Show Strong Advance

Ahead of its formal audited statements, Bespoke Extracts has released key preliminary data. The company forecasts annual revenue of approximately $1.5 million for FY 2025. This figure represents a substantial 34% increase compared to the $1.12 million reported in the prior fiscal year. A reliable estimate for the full-year net loss is not yet available.

This positive trajectory was already evident in the company's third-quarter results. For that period, Bespoke Extracts generated revenue of nearly $468,000, marking clear growth year-over-year. The business also achieved a gross margin of 50% for the quarter and reduced its net loss by 72% compared to the same period in the previous year.

SEC Filing Deadline Extended

The management of Bespoke Extracts has formally requested additional time from the U.S. Securities and Exchange Commission (SEC) to file its Form 10-K annual report. Company officials cite the extra time required to compile, review, and complete disclosures related to the financial data as the reason for the delay.

The original filing deadline was March 31. Under the extension, the complete annual report is now expected to be submitted within 15 calendar days of that original due date, targeting mid-April.

Awaiting the Full Financial Picture

The upcoming comprehensive report, anticipated in mid-April, will provide necessary clarity on the company's detailed cost structure and full-year profitability. These finalized numbers will reveal whether the operational progress demonstrated in the fall quarters was sufficient to drive a sustainable improvement in annual profitability.

The preliminary revenue jump indicates robust demand for the company's specialized cannabis products, even as it navigates the administrative process of finalizing its annual accounting.